Wall Street is positive on P3 Health Partners Inc (PIII). On average, analysts give P3 Health Partners Inc a Buy rating. The average price target is $3.5, which means analysts expect the stock to increase by 60.55% over the next twelve months. That average ranking earns P3 Health Partners Inc an Analyst Rating of 36, which is better than 36% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating PIII a Buy today. Find out what this means to you and get the rest of the rankings on PIII!